FOR INVESTORS

Driven by a team of fast-moving entrepreneurs, management leaders, and industry-recognized horticulturists, Invictus MD is powering the future of the legal cannabis industry.

Since going public in 2014, Invictus MD has grown through early acquisitions and rapid business development to what it is today. With our focus completely on regulated cannabis production, we now manage and operate several licensed facilities across Canada with access to over 250 acres of cultivation space. All our properties revolve around our core initiative to build out a dominant production profile that can support a wide variety of high-quality strains. With the proper care and attention to detail, we are dedicated to continuously growing with this new industry in an honest, transparent and socially-responsible way.

All our properties revolve around our core initiative to build out a dominant production profile that can support a wide variety of high-quality strains. With the proper care and attention to detail, we are dedicated to continuously growing with this new industry in an honest, transparent and socially-responsible way.

TSX VENTURE: IMH
UNITED STATES OTC: IVITF
FRANKFURT STOCK EXCHANGE: 8IS

QUICK FACTS

Large Canadian Footprint of cannabis real estate

We own more than 250 acres of buildable property across the country, allowing for millions of sq. ft. of canopy space as demand dictates.

Proven performance

A one million dollar dividend was paid out in 2016, representing the first ever dividend paid out by a cannabis company.

Strong production profile

By focusing on expanding our production capability, we are forecasted to produce in excess of 50,000 kgs by 2020.

Optimized from the ground up

With presence in Alberta and Ontario, all of our facilities are designed and maintained for optimal plant growth. Site-specific conditions such as climate, humidity, and fresh water supply is leveraged for their passive benefits, resulting in a highly-efficient cultivation system with low operational costs.

Our platform includes ancillary products such as plant nutrients and fertilizers, giving us direct control over every element of the growing process. Having this visibility is a crucial component to our ability to produce a safe and organic product, time and time again.

Data-driven production

Our cultivation methodology combines proven agricultural techniques with the advantages of automation and technology. Conditions that are critical for healthy plant growth—temperature, humidity, carbon dioxide levels—are constantly monitored and optimized by an autonomous system. This mitigates risk of human error while ensuring that each facilities remain lean in operation.

From clone to bud, every equipment and system design has been engineered to ensure consistent growth, high quality yields, and competitive cost per gram.

No detail is too small. We obsessively care over every step of the cultivation process.

DOWNLOAD OUR INVESTOR DECK

There’s much more information on our team, production properties, and our projected growth curve with the timing of a recreational roll-out. It also includes:

  • Breakdown of facilities
  • Capitalization structure
  • Future Harvest performance
  • Company road map from going public
  • Combined Cannabis Production Profile
  • Management & Board of Directors

Analyst coverage

Russell Stanley
Echelon Wealth Partners

Neil Maruoka
Canaccord Genuity

All analyst coverage is conducted by third parties. As such the content of any analyst coverage should not be considered financial advice or forecasting that is approved or endorsed by Invictus MD Strategies Corp.

OUR RESOURCES

Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

14Jul

Vancouver, BC, July 14, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Acreage Pharms Ltd. (“Acreage Pharms”) located near Edson, Alberta, utilizing a multi-room indoor perpetual growing […]

Read more

Invictus MD Provides a Corporate Update on AB Laboratories Inc. and AB Ventures Inc.

13Jul

Vancouver, BC, July 13, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to provide an update that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), AB Laboratories Inc. (“AB Labs”) located in Hamilton, Ontario, utilizing a multi-room indoor […]

Read more

Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF

23Jun

Vancouver, BC, June 23, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) (“HMMJ ETF”), which is trading, and is the first ETF to offer direct exposure to North American-listed stocks that […]

Read more

CONNECT WITH US

Find out how you can get involved in today’s fastest growing industry.

 

Get in touch

twitter-icon
facebook-icon
instagram-icon
linkedin-icon